Latest Breaking News On - Specialty generics - Page 10 : comparemela.com

Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients

Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients
vietreader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietreader.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesClin apherDerek belzMarkus bartenPrnewswire mallinckrodtHeather guzziDermatol venereolDanielj specialeUniversity heartAmerican heart associationGreen room communicationsExchange commissionMallinckrodt pharmaceuticalsInternational society of heartInternational society for heart

Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients

Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Hea

United kingdomUnited statesMarkus bartenDerek belzHeather guzziDanielj specialeDermatol venereolClin apherCommittee of the american society for apheresisVascular center hamburgAmerican heart associationGreen room communicationsInternational society for heartInternational society of heartMallinckrodt pharmaceuticalsUniversity heart

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023

/PRNewswire/ Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific posters detailing.

United statesCity ofUnited kingdomSan franciscoKhurram jamilHeather guzziDerek belzKevin moorePrashant pandyaPrnewswire mallinckrodtRyan taylorR todd frederickDanielj specialeInternational club of ascitesExchange commissionUniversity college london

Mallinckrodt plc: Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients

- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its

United statesUnited kingdomDerek belzMarkus bartenHeather guzziDermatol venereolClin apherDanielj specialePrnewswire mallinckrodtEuropean society for organ transplantationUniversity heartUnited kingdom photopheresis societyInternational society of heartGreen room communicationsVascular center hamburgCentre study

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023

/PRNewswire/ Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical.

United statesSan diegoTufts medical centerFredric gordonDerek belzKhurram jamilClin transplHeather guzziRyan taylorDanielj specialePrashant pandyaUnited states census bureauClinical development critical care at mallinckrodtUniversity of wisconsin hospitalAmerican college of gastroenterologyNational organization for rare disorders